Brief: Medexus Pharmaceuticals Qtrly Revenue Was $16.4 Mln Compared To $3.4 Mln For Fiscal Quarter Ended Sept 30, 2018
Nov 29 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PHARMACEUTICALS REPORTS OPERATING AND FINANCIAL
RESULTS
FOR THE SECOND QUARTER OF FISCAL 2020
* MEDEXUS PHARMACEUTICALS INC - QTRLY REVENUE WAS $16.4
MILLION
COMPARED TO $3.4 MILLION FOR FISCAL QUARTER ENDED SEPTEMBER 30,
2018
Source text for Eikon: ID:nGNX4Hn3G0
Further company coverage: MDP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million